There's the topline Cobra data that was delayed from Q423, possibly more results from previous cohorts of the Secure trial who have had additional therapy cycles under the FDA early access program and also at some point I assume we will see the first round of results from the 12Mbq cohort of the Secure trial
I'm not sure if there's any news likely from the Sartate CLO4 trial? Been quiet on that front since the last news which appeared to be good(patients granted access to further therapy cycles under FDA eap)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.51 |
Change
-0.010(0.40%) |
Mkt cap ! $811.7M | |||
| Open | High | Low | Value | Volume |
| $2.53 | $2.63 | $2.42 | $4.767M | 1.905M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 25437 | $2.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.35 | 44625 | 8 |
View Market Depth
| Last trade - 15.59pm 30/06/2025 (20 minute delay) ? |
| CU6 (ASX) Chart |